Advisory Research’s Lydall, Inc. LDL Stock Holding History
Bought
Maintained
Sold
Other funds holding LDL
CIP
ICOM
Advisory Research's LDL Position: Q1 2018 in Review
Advisory Research sold out of Lydall, Inc. (LDL) in Q1 2018, closing a stake of 328,396 shares — an estimated $16.7M sold.
Advisory Research first reported a position in LDL in Q1 2014 and held it in 16 quarters. The position peaked at $24.4M in Q3 2017. 157 funds tracked by Wall St. Rank hold LDL as of Q1 2018.
- Advisory Research reported no remaining Lydall, Inc. position as of Q1 2018 after selling out during the quarter.
- Advisory Research sold 328,396 Lydall, Inc. shares in Q1 2018, an estimated $16.7M.
- Advisory Research first reported a position in Lydall, Inc. in Q1 2014 and held it in 16 quarters.
- Advisory Research's Lydall, Inc. position peaked at $24.4M in Q3 2017.
- 157 funds tracked by Wall St. Rank held Lydall, Inc. as of Q1 2018.
Based on Advisory Research's 13F filing for Q1 2018, filed 15 May 2018.